I too believe that the choice of indications is more stategic than them just being 4 unmet/orphan drugs. Testing spread / range of potential applications
- Forums
- ASX - By Stock
- NEU
- Ann: 2023 Results webinar
Ann: 2023 Results webinar, page-119
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.62 |
Change
0.000(0.00%) |
Mkt cap ! $2.635B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 203 | $22.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.59 | 714 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 109 | 22.050 |
1 | 240 | 21.730 |
6 | 1276 | 21.650 |
1 | 759 | 21.630 |
1 | 1755 | 21.590 |
Price($) | Vol. | No. |
---|---|---|
19.590 | 714 | 5 |
19.740 | 9 | 1 |
20.150 | 18 | 1 |
20.240 | 471 | 1 |
20.370 | 235 | 4 |
Last trade - 10.05am 28/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable